Patents by Inventor Michael Tullius

Michael Tullius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
    Patent number: 8383132
    Abstract: Immunogenic compositions comprising recombinant intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens and immunostimulatory molecules are provided. Exemplary immunogenic compositions include, but are not limited to, recombinant BCG expressing Mycobacteria major extracellular proteins and immunostimulatory molecules.
    Type: Grant
    Filed: January 7, 2011
    Date of Patent: February 26, 2013
    Assignee: The Regents of the University of California
    Inventors: Marcus A. Horwitz, Michael Tullius
  • Immunostimulatory Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use
    Publication number: 20110129492
    Abstract: Immunogenic compositions comprising recombinant intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens and immunostimulatory molecules are provided. Exemplary immunogenic compositions include, but are not limited to, recombinant BCG expressing Mycobacteria major extracellular proteins and immunostimulatory molecules.
    Type: Application
    Filed: January 7, 2011
    Publication date: June 2, 2011
    Inventors: Marcus A. Horwitz, Michael Tullius
  • Recombinant intracellular pathogen immunogenic compositions and methods for use
    Publication number: 20070128216
    Abstract: Immunogenic compositions comprising recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions include, but are not limited to attenuated recombinant Mycobacteria expressing the major extracellular non-fusion proteins of Mycobacteria and/or other intracellular pathogens. Other embodiments are provided wherein the recombinant attenuated intracellular pathogen is auxotrophic.
    Type: Application
    Filed: October 15, 2004
    Publication date: June 7, 2007
    Inventors: Marcus Horwitz, Gunter Harth, Michael Tullius